Latest news
Glaukos completes enrollment in PRESERFLO MicroShunt pivotal study - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Tue, 04 Aug 2026 19:44:43 GMTEyeWorld Weekly, July 31, 2026 - EyeWorldEyeWorld · Fri, 31 Jul 2026 16:03:01 GMTGlaukos Latest Results: Sales Guidance Raised to $680.000M-$700.000M - scanx.tradescanx.trade · Wed, 29 Jul 2026 07:00:00 GMTGlaukos Completes Enrollment for Glaucoma Implant Study - Orange County Business JournalOrange County Business Journal · Mon, 27 Jul 2026 16:43:17 GMTGlaukos Completes Enrollment in US Pivotal Study of Preserflo MicroShunt for POAG - eyewire.newseyewire.news · Mon, 27 Jul 2026 12:59:27 GMTGlaukos (GKOS) Completes Patient Enrollment for Groundbreaking G - GuruFocusGuruFocus · Mon, 27 Jul 2026 12:07:00 GMTGlaukos completes enrollment in pivotal trial of PRESERFLO MicroShunt for treatment-resistant glaucoma - Ophthalmology Times EuropeOphthalmology Times Europe · Mon, 27 Jul 2026 07:00:00 GMTGlaukos completes enrollment with at least 110 glaucoma patients - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT